Neoleukin Therapeutics Inc (NASDAQ:NLTX)

0.59
Delayed Data
As of 3:16pm ET
 -0.0201 / -3.29%
Today’s Change
0.38
Today|||52-Week Range
3.84
+15.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.0025.0M
 
 
 
Operating ExpensesGross Income0.000.000.00----
General Expenses21.3M37.6M51.1M48.5M
 
 
 
 
 
Research And Development15.8M28.4M36.3M32.8M
 
 
 
 
 
Total Operating Expenses21.3M37.6M51.1M48.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.3M-37.6M-51.1M-23.5M
 
 
 
 
 
Extraordinary Credit0.0081.0K0.000.00
 
 
Extraordinary Charge-52.0K0.000.00-10.4M
 
 
 
Interest Expense On Debt99.0K1.0K4.0K4.0K
 
 
 
 
 
Other Expenses-369.0K-56.0K-58.0K780.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-21.9M-37.0M-50.2M-31.6M
 
 
 
 
 
Net Income-21.9M-37.0M-50.2M-31.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.6M18.9M23.5M23.5M
 
 
 
 
 
Shares To Calculate EPS Diluted12.6M18.9M23.5M23.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.73-$1.96-$2.14-$1.34
 
 
 
 
 
EPS Diluted-$1.73-$1.96-$2.14-$1.34